Patricia is currently the Chief Financial Officer of Vividion Therapeutics, Inc., a position she has held since March 2021. From January 2013 to May 2020, she served as Chief Financial Officer of Zafgen, Inc., now Larimar Therapeutics Inc.
Previously, from 2011 to 2012, Patricia provided independent consulting services to biotechnology companies in a variety of areas, including interim chief financial officer services, fundraising, deal structures, financial planning, organizational structure, investor relations, and business development. From 2004 to 2011, Patricia served as the Vice President of Finance, Treasurer, and Principal Financial Officer of Alnylam Pharmaceuticals, Inc. Prior to Alnylam, she was Director of Finance at Alkermes, Inc.
Patricia began her career as an auditor at Deloitte & Touche, LLP. She graduated summa cum laude from Bryant College with a BS in Business Administration. She currently serves as a member of the Board of Directors at multiple publicly traded and privately held companies including Deciphera Pharmaceuticals.